Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2020 Filed Sep 4, 2020 20:18 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 54,616 | $110.57 | $6,038,727.27 |
DisclosureSEC source: 0001022079-20-000164 · wf-form4_159925068530041.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,187 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $110.00 to $110.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:18 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Exercise / conversionCommon Stock | 58,392 | $66.51 | $3,883,651.92 |
DisclosureSEC source: 0001022079-20-000164 · wf-form4_159925068530041.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:39 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 203 | $113.73 Strike: $0.00 | $23,087.19 |
DisclosureSEC source: 0001022079-20-000144 · wf-form4_159372232940051.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,693.011 Underlying: Common Stock · 203 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:33 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 72,596 | $71.17 Strike: $71.17 | $5,166,657.32 |
DisclosureSEC source: 0001022079-20-000136 · wf-form4_159182116205657.xml · derivative · entry 5 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 72,596 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:33 UTC |
GUINAN MARKExecutive Vice President & CFO
|
SaleCommon Stock | 8,524 | $118.60 | $1,010,980.50 |
DisclosureSEC source: 0001022079-20-000136 · wf-form4_159182116205657.xml · nonDerivative · entry 4 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,579 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $118.16 to $119.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:33 UTC |
GUINAN MARKExecutive Vice President & CFO
|
SaleCommon Stock | 18,246 | $117.65 | $2,146,623.65 |
DisclosureSEC source: 0001022079-20-000136 · wf-form4_159182116205657.xml · nonDerivative · entry 3 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,103 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $117.15 to $118.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:33 UTC |
GUINAN MARKExecutive Vice President & CFO
|
SaleCommon Stock | 45,826 | $116.81 | $5,352,980.89 |
DisclosureSEC source: 0001022079-20-000136 · wf-form4_159182116205657.xml · nonDerivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,349 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $116.15 to $117.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:33 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 72,596 | $71.17 | $5,166,657.32 |
DisclosureSEC source: 0001022079-20-000136 · wf-form4_159182116205657.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 779 | $63.42 Strike: $63.42 | $49,404.18 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 15 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 779 shares Expires 2022-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 790 | $60.22 Strike: $60.22 | $47,569.85 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 14 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 790 shares Expires 2022-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 6,111 | $57.57 Strike: $57.57 | $351,779.72 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 13 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,111 shares Expires 2022-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 820 | $61.62 Strike: $61.62 | $50,524.30 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 12 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 820 shares Expires 2022-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 151 | $58.37 Strike: $58.37 | $8,813.87 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 11 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 151 shares Expires 2022-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 532 | $58.37 Strike: $58.37 | $31,052.84 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 10 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 532 shares Expires 2022-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 2,547 | $57.74 Strike: $57.74 | $147,063.78 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · derivative · entry 9 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,547 shares Expires 2021-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. F2 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on December 6, 2012, the second on December 6, 2013 and the final on December 6, 2014. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
SaleCommon Stock | 11,730 | $116.60 | $1,367,718.00 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 8 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,505 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionCommon Stock | 779 | $63.42 | $49,404.18 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 7 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionCommon Stock | 790 | $60.22 | $47,569.85 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 6 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionCommon Stock | 6,111 | $57.57 | $351,779.72 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 5 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionCommon Stock | 820 | $61.62 | $50,524.30 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 4 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionCommon Stock | 151 | $58.37 | $8,813.87 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 3 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionCommon Stock | 532 | $58.37 | $31,052.84 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 2 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:31 UTC |
RING TIMOTHY MDirector
|
Exercise / conversionCommon Stock | 2,547 | $57.74 | $147,063.78 |
DisclosureSEC source: 0001022079-20-000135 · wf-form4_159182109282326.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 7, 2020. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:45 UTC |
Lassiter Wright IIIDirector
|
GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000129 · wf-form4_159009393260707.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,882 F1 · security: Represents an award of restricted share units. Read SEC document |
| May 19, 2020 Filed May 21, 2020 16:44 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000128 · wf-form4_159009383826549.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,482 F1 · security: Represents an award of restricted stock units. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:42 UTC |
STANZIONE DANIELDirector
|
GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000127 · wf-form4_159009372719786.xml · nonDerivative · entry 1 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,572 F1 · security: Represents an award of restricted share units. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:41 UTC |
RING TIMOTHY MDirector
|
GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000126 · wf-form4_159009364368927.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,505 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:40 UTC |
PFEIFFER GARY MDirector
|
GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000125 · wf-form4_159009358467185.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,513 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:39 UTC |
MAIN TIMOTHY LDirector
|
GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000124 · wf-form4_159009352665799.xml · nonDerivative · entry 1 MAIN TIMOTHY L · CIK 0001196744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,588 F1 · security: Represents an award of restricted share units. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:37 UTC |
Torley HelenDirector
|
GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000123 · wf-form4_159009341983894.xml · nonDerivative · entry 1 Torley Helen · CIK 0001528185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,897 F1 · security: Represents an award of restricted share units. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:35 UTC |
Gregg Vicky BDirector
|
GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000122 · wf-form4_159009333493069.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,844 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes approximately 149 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. F3 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:34 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000121 · wf-form4_159009326198434.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,783 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 18, 2020 Filed May 20, 2020 20:33 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 5 | $107.42 | $537.10 |
DisclosureSEC source: 0001022079-20-000109 · wf-form4_159000678717251.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,035 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. F2 · balance_after: The amount includes approximately 59 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 20:45 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 11,717 | $71.17 Strike: $71.17 | $833,898.89 |
DisclosureSEC source: 0001022079-20-000103 · wf-form4_158810667839365.xml · derivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,717 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 20:45 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 11,717 | $112.01 | $1,312,432.89 |
DisclosureSEC source: 0001022079-20-000103 · wf-form4_158810667839365.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,747 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $112.00 to $112.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 20:45 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 11,717 | $71.17 | $833,898.89 |
DisclosureSEC source: 0001022079-20-000103 · wf-form4_158810667839365.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 20:37 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
SaleCommon Stock | 2,500 | $110.00 | $275,000.00 |
DisclosureSEC source: 0001022079-20-000101 · wf-form4_158810623301414.xml · nonDerivative · entry 2 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,390 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 27, 2020. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 20:37 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
SaleCommon Stock | 2,500 | $112.03 | $280,075.00 |
DisclosureSEC source: 0001022079-20-000101 · wf-form4_158810623301414.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,890 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 27, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $112.00 to $112.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:04 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 403 | $76.55 Strike: $0.00 | $30,850.46 |
DisclosureSEC source: 0001022079-20-000093 · wf-form4_158594785447752.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,433.781 Underlying: Common Stock · 403 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:37 UTC |
Davis J. E.EVP, General Diagnostics
|
SaleCommon Stock | 500 | $90.15 | $45,073.00 |
DisclosureSEC source: 0001022079-20-000089 · wf-form4_158447741639881.xml · nonDerivative · entry 5 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,086 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F6 · price: This transaction was executed in multiple trades at prices ranging from $89.67 to $90.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:37 UTC |
Davis J. E.EVP, General Diagnostics
|
SaleCommon Stock | 421 | $88.53 | $37,269.03 |
DisclosureSEC source: 0001022079-20-000089 · wf-form4_158447741639881.xml · nonDerivative · entry 4 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,586 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $88.36 to $88.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:37 UTC |
Davis J. E.EVP, General Diagnostics
|
SaleCommon Stock | 1,307 | $87.81 | $114,771.59 |
DisclosureSEC source: 0001022079-20-000089 · wf-form4_158447741639881.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,007 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $87.23 to $88.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:37 UTC |
Davis J. E.EVP, General Diagnostics
|
SaleCommon Stock | 1,085 | $86.65 | $94,019.59 |
DisclosureSEC source: 0001022079-20-000089 · wf-form4_158447741639881.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,314 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $86.19 to $87.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:37 UTC |
Davis J. E.EVP, General Diagnostics
|
SaleCommon Stock | 200 | $85.59 | $17,118.00 |
DisclosureSEC source: 0001022079-20-000089 · wf-form4_158447741639881.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,399 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $85.19 to $85.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 20:55 UTC |
Lassiter Wright IIIDirector
|
GrantCommon Stock | 351 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000087 · wf-form4_158439209905299.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351 F1 · security: Represents an award of restricted share units. Read SEC document |
| March 11, 2020 Filed Mar 12, 2020 21:00 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 2,175 | $104.25 | $226,743.75 |
DisclosureSEC source: 0001022079-20-000077 · wf-form4_158404681478971.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,087 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 24, 2018. Read SEC document |
| March 11, 2020 Filed Mar 12, 2020 20:57 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 2,501 | $104.25 | $260,729.25 |
DisclosureSEC source: 0001022079-20-000073 · wf-form4_158404662542081.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,411 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 21:02 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 3,846 | $106.46 | $409,445.16 |
DisclosureSEC source: 0001022079-20-000079 · wf-form4_158404693046672.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,599 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The numbers in this column reflect beneficial ownership as of March 10, 2020, and do not include 19 shares that were inadvertently reported as beneficially owned by the reporting person on the Form 4 filed on February 28, 2020. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 21:02 UTC |
Davis J. E.EVP, General Diagnostics
|
GrantCommon Stock | 7,359 | $106.46 | $783,439.14 |
DisclosureSEC source: 0001022079-20-000079 · wf-form4_158404693046672.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,445 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2017, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 21:00 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 2,174 | $106.46 | $231,444.04 |
DisclosureSEC source: 0001022079-20-000077 · wf-form4_158404681478971.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,262 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.